Telehealthcare for asthma:a Cochrane review by McLean, Susannah et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Telehealthcare for asthma
Citation for published version:
McLean, S, Chandler, D, Nurmatov, U, Liu, J, Pagliari, C, Car, J & Sheikh, A 2011, 'Telehealthcare for
asthma: a Cochrane review' CMAJ : Canadian Medical Association Journal, vol 183, no. 11, pp. E733-42.
DOI: 10.1503/cmaj.101146
Digital Object Identifier (DOI):
10.1503/cmaj.101146
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
CMAJ : Canadian Medical Association Journal
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 28. Apr. 2017
There has been an increase in the preva-lence of asthma in recent decades,1–3 andthe Global Initiative for Asthma esti-
mates that 300 million people worldwide now
have the disease.4 The highest prevalence rates
(30%) are seen in economically developed coun-
tries.5–8 There has also been an increase in the
prevalence of asthma affecting both children and
adults in many economically developing and
transition countries.9–11
Asthma’s high burden of disease requires
improvements in access to treatments.7,12,13 Pat-
terns of help-seeking behaviour are also relevant:
delayed reporting is associated with morbidity
and the need for emergency care.
It is widely believed that telehealthcare inter-
ventions may help address some of the challenges
posed by asthma by enabling remote delivery of
care, facilitating timely access to health advice,
supporting self-monitoring and medication con-
cordance, and educating patients on avoiding trig-
gers.14–16 The precise role of these technologies in
the management of care for people with long-term
respiratory conditions needs to be established.17
The objective of this study was to systemati-
cally review the effectiveness of telehealthcare
interventions among people with asthma in terms
of quality of life, number of visits to the emer-
gency department and admissions to hospital for
exacerbations of asthma.
Methods
Population
We included trials that had involved both chil-
dren and adults. We were interested in random-
ized controlled trials done in both family practice
and hospital settings. Studies had to involve par-
ticipants who had received a diagnosis of asthma
from a physician. Studies involving people with
chronic obstructive pulmonary disease were ex -
cluded, as they are being included in a separate
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Background: Telehealthcare has the potential
to provide care for long-term conditions that
are increasingly prevalent, such as asthma. We
conducted a systematic review of studies of
telehealthcare interventions used for the treat-
ment of asthma to determine whether such
approaches to care are effective.
Methods: We searched the Cochrane Airways
Group Specialised Register of Trials, which is
derived from systematic searches of bibliographic
databases including CENTRAL (the Cochrane
Central Register of Controlled Trials), MEDLINE,
Embase, CINAHL (Cumulative Index to Nursing
and Allied Health Literature) and PsycINFO, as
well as other electronic resources. We also
searched registers of ongoing and unpublished
trials. We were interested in studies that mea-
sured the following outcomes: quality of life,
number of visits to the emergency department
and number of admissions to hospital. Two
reviewers identified studies for inclusion in our
meta-analysis. We extracted data and used fixed-
effect modelling for the meta-analyses.
Results: We identified 21 randomized con-
trolled trials for inclusion in our analysis. The
methods of telehealthcare intervention these
studies investigated were the telephone and
video- and Internet-based models of care.
Meta-analysis did not show a clinically impor-
tant improvement in patients’ quality of life,
and there was no significant change in the
number of visits to the emergency depart-
ment over 12 months. There was a significant
reduction in the number of patients admit-
ted to hospital once or more over 12 months
(risk ratio 0.25 [95% confidence interval 0.09
to 0.66]).
Interpretation: We found no evidence of 
a clinically important impact on patients’
quality of life, but telehealthcare interven-
tions do appear to have the potential to
reduce the risk of admission to hospital, 
particularly for patients with severe asthma. 
Further re search is required to clarify the
cost -effectiveness of models of care based on
telehealthcare.
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systematic review.17 No studies were excluded on
the basis of age, sex, race, ethnicity or language
spoken by the participants.
Intervention
Our conceptual definition of telehealthcare, as
adapted from Miller,18 is “the provision of per-
sonalized healthcare at a distance.” This consti-
tutes the following three factors: information
obtained from the patient, whether by conversa-
tion, video, electrocardiography, oxygen satura-
tion, etc., that details the patient’s condition;
electronic transfer of this information to a health
care professional over a distance; and personal-
ized feedback tailored to the patient and pro-
vided by a health care professional who exer-
cises clinical skills and judgement.
“At a distance” refers to health care that uses a
tool of distance communication that works without
the simultaneous physical presence of the partici-
pants in the interaction. According to this defini-
tion, the technology used might be the tele phone,
e-mail, the internet or any other networked or
mobile device. The novelty or sophistication of the
technology is irrelevant. Feedback from the health
care professional to the patient could be synchro-
nous or asynchronous (i.e., by store-and-forward
technology, in which a patient’s data are kept in an
electronic repository and forwarded to a health
care professional on request); we also stipulated
that the health care pro fessional should provide
advice tailored to the consulting patient.
Comparison
In most instances, telehealthcare was compared
with face-to-face usual care. However, in some
studies, the control arm also involved an increase in
the frequency or intensity of contact between health
care professionals and patients.
Outcomes
The outcomes studied included process measures
and clinical parameters. The key outcomes in -
cluded asthma-specific quality of life as mea-
sured by the Juniper scale, the risk of one or
more visits to the emergency department for
asthma over 12 months, and the number of
patients with one or more admissions to hospital
over 12 months.
Identifying studies for inclusion
We identified randomized controlled trials using
the Cochrane Airways Group Specialised Regis-
ter of Trials, which is derived from systematic
searches of the following bibliographic data-
bases: CENTRAL (the Cochrane Central Regis-
ter of Controlled Trials), MEDLINE, Embase,
CINAHL (Cumulative Index to Nursing and
Allied Health Literature) and PsycINFO. Manual
searches of respiratory journals and abstracts from
meetings also contribute to the Cochrane Airways
Group Specialised Register of Trials. All records
in the register that had been coded as “asthma”
were searched using the telehealthcare terms spec-
ified in Appendix 1 (available at www .cmaj .ca
/lookup /suppl /doi :10 .1503 /cmaj .101146 / - /DC1).
Extraction and management of data
The following data were extracted from the
included studies by one reviewer and indepen-
dently checked by a second reviewer: country
and setting; the design of the study; the number
of participants, their mean ages and the range of
ages; a description of the intervention being
investigated and of how the control group was
managed; measures of symptoms (see Table 1
and Appendix 2 [available at www .cmaj .ca
/lookup /suppl /doi :10 .1503 /cmaj .101146 / - /DC1]);
quality of life; use of the health care system, such
as visits to the emergency department or admis-
sions to hospital; cost data (from the perspective
of the health care provider); monitoring of peak
expiratory flow and patient diaries; patient’s
forced expiratory volume in one second and
forced vital capacity; patient satisfaction; a
description of adverse events; and patient with-
drawal from the study.
Analysis
We assessed the risk of bias in each trial using
the methods detailed in the Cochrane Handbook
for Systematic Reviews of Interventions.19
We calculated summary statistics for our pri-
mary outcomes. We calculated risk ratios (RRs)
for the dichotomous variables; for the asthma-
related quality of life score, a continuous variable,
we calculated mean differences. We used the
authors’ published data. To create forest plots,
data had to be compatible across studies. For ex -
ample, for quality of life, we included only studies
that reported using the Juniper scale; for visits to
the emergency department, we included only
studies with results that could be summarized into
the variable of the number of patients with one or
more visits to the emergency department over
12 months of follow-up. In this way, we produced
meaningful comparative data across studies. We
also included raw data in our analyses where it
was supplied to us by the authors. The data from
all studies (i.e., whether it was possible to include
these data in the meta-analysis or not) are summa-
rized in Appendix 2, which provides an overview
of the results from all of the eligible studies.
We assessed the statistical heterogeneity
between studies and the likely impact of this het-
erogeneity on our meta-analysis using the I2 statis-
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tic.19 Where I2 was 40% or less, we used a fixed-
effect model. We used a random-effects model if
the impact of the statistical heterogenity was high
(i.e., I2 > 40%). Pooled data were presented graph-
ically with forest plots. We planned subgroup
analyses according to the type of technology used
for telehealthcare. We used funnel plots to assess
possible bias in reporting and publication (data
available upon request from the authors).
Results
Description of studies
Our searches identified 525 abstracts. Initially,
76 reports had seemed possibly relevant, but 21
trials (25 reports) were included after thorough
full-text review. Appendix 1 details our search
strategy, which is illustrated by a PRISMA flow
chart in Figure 1. A description of the studies we
included is given in Table 1.20–44 Two studies had
to be translated from Japanese, and one study
was translated from Italian. It was only possible
to obtain partial translations of the Japanese
reports. In addition, we found 14 ongoing trials
that have reported preliminary findings in
abstract form and 21 trials that have yet to report
in any  format.
Telehealthcare interventions studied
The most common model of intervention stud-
ied was an initial face-to-face introduction with
follow-up exchanges between patient and health
care professional using a telephone, the Internet
or text messages. Seven studies applied this
 format.20,24,27,30,31,35,42
Risk of bias in the included studies
A summary of the risk of bias in the included stud-
ies can be seen in Appendix 3 (available at www
.cmaj .ca /lookup /suppl /doi :10 .1503 /cmaj .101146
/ - /DC1).
Effectiveness of telehealthcare
The impact of telehealthcare interventions on the
quality of life of people with asthma was assessed
in 14 trials.22,24,26,28,29,31,32,34,38–42,45 We did a meta-
analysis of the nine studies that used Juniper’s
validated quality-of-life questionnaires (Fig-
ure 2A). None of the studies that looked at qual-
ity of life reported a clinically important differ-
ence (i.e., a difference of more than 0.5 points
on the Juniper questionnaire). Pooling the data
from nine of these studies showed a statistically
significant mean difference of 0.08 (95% CI
0.01 to 0.16).
Subgroup analyses were done for the
 telephone-only studies and for the studies look-
ing at all other technologies. The five telephone-
only studies pooled to give a mean difference of
0.04 (95% CI –0.05 to 0.12, Figure 2B). The
four studies looking at all other technologies
pooled to give a greater mean difference of 0.21
(95% CI 0.07 to 0.34, Figure 2C); however, this
difference is still less than the minimum clinically
significant difference.
Ten studies (published in 11 reports) reported
data on visits to the emer gency depart-
ment.22,24,27,30,32,34,36,39,41,42,46 The effect of telehealthcare
interventions on the number of patients with one or
more visits to the emergency department over 12
months is shown in Figure 3. This meta-analysis
included five trials representing 619
patients.22,27,34,39,42 It revealed a nonsignificant
increase in RR of one or more visits to the emer-
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Articles identified through 
electronic searches 
n = 493 
• CENTRAL n = 71 
• CINAHL n = 1 
• Conference proceedings n = 56 
• Embase n = 88 
• Web of Science n = 3 
• MEDLINE n = 173 
• National Research Register UK n = 25 
• PsycINFO n = 2 
• Websites n = 35 
• Other n = 39
Articles identified by 
experts in the field 
n = 30
Articles identified by reviewing 
the references 
n = 2
Reports 
n = 525
Excluded n = 449 
 • Did not meet  
    inclusion criteria 
Citations identified for 
full-text appraisal for 
relevance and quality 
n = 76
Excluded n = 51
• Did not meet 
   inclusion criteria n = 33 
• Published as  
   abstract only n = 14  
• Additional reports of already 
excluded trials n = 4 
Trials included in the 
final review* 
n = 21
Ongoing and  
unpublished trials  
n = 21  
• NIHR n = 4 
• ClinicalTrials.gov n = 13 
• controlled-trials.com n = 3 
• ANZCTR n = 1
Figure 1: Identification of relevant literature on the use of telehealthcare for the
treatment of asthma. ANZCTR = Australian New Zealand Clinical Trials Registry,
CENTRAL = the Cochrane Central Register of Controlled Trials,  CINAHL = Cumula-
tive Index to Nursing and Allied Health Literature, NIHR = National Institutes of
Health Research.*The 21 trials included in the final review were published across
25 reports.
gency department (RR 1.04 [95% CI 0.84 to 1.28]).
Six studies presented data on admissions to
hospital.22,28,30,34,35,39 For two studies,30,35 these admis-
sions occurred over three months. For the re -
maining four studies, admissions to hospital were
recorded as having occurred over 12 months.
For the two studies that provided data on out-
comes at three months, meta-analysis showed high
heterogeneity (I2 = 78%), so the analysis was done
using random effects (RR 0.91 [95% CI 0.07 to
12.69], Figure 4A). The confidence intervals were
very wide, suggesting that it is difficult to draw
any firm conclusion regarding the risk of admis-
sion to hospital over three months in the telehealth-
care group versus the control group.
Meta-analysis of the four studies that reported
the number of patients admitted to hospital once or
more within 12 months of randomization is shown
in Figure 4B (summary RR 0.25 [95% CI 0.09 to
0.66]). This includes data from 499 patients and
suggests that telehealthcare reduced the risk of
admission to hospital.
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0.10 (–0.05 to 0.25)
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Study or subgroup
Clark 200724
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0.00 (–0.14 to 0.14)
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Intervention Control Mean difference
(95% CI)
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 control
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Study or subgroup
Chan 200722
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Van der Meer 200940
Willems 200842
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Mean
6.1
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6.29
5.73
SD
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n
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55
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Mean
5.8
6.2
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5.48
SD
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0.7
0.69
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n
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54
280
0.30 (–0.11 to 0.71)
0.00 (–0.24 to 0.24)
0.32 (0.12 to 0.52)
0.25 (–0.18 to 0.68)
0.21 (0.07 to 0.34) 
Intervention Control Mean difference
(95% CI)
-1 -0.5 0 0.5 1
Favours
control
Favours 
intervention
C
Mean difference (95% CI)
Total 
Total 
Figure 2: Forest plots of the mean differences and 95% confidence intervals (CIs) in the measurement of quality of life among patients
with asthma as per Juniper’s questionnaire (A), as suggested by studies investigating telehealthcare delivered by telephone only (B)
and as suggested by studies investigating telehealthcare delivered by all other technologies (C). SD = standard deviation.
The results of studies examining symptoms as
an outcome are summarized in the Table of
Results in Appendix 2. The results suggest that
symptom scores may be improved with tele-
healthcare. However, in many instances, there
was no difference between groups.
Secondary outcomes: adverse events
There were few adverse events reported in the
studies. Two people with asthma died during the
intervention arm of one study,29 but correspon-
dence with the study’s authors confirmed that
these deaths were not related to asthma. This is
important, as it may be expected that if telehealth-
care is used as a substitute for face-to-face care,
then a reduction in the intensity of health care
may place a patient at risk. Larger studies are
required to address this concern more fully.
Interpretation
Main findings
Our meta-analyses of the published trial evidence
failed to show an appreciable impact of tele-
healthcare on disease-specific quality of life or
risk of attendance at the emergency department
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Figure 4: Forest plots of the risk ratios (RRs) and 95% confidence intervals (CIs) for the numbers of patients admitted to hospital once
or more over 3 months (A), and the number of patients admitted to hospital once or more over 12 months (B).*Because of high hetero-
geneity, analysis was performed using a random effects model.
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Figure 3: Forest plot of the risk ratios (RRs) and 95% confidence intervals (CIs) of the numbers of patients who visited the emergency
department once or more over 12 months.
for people with asthma. However, meta-analysis
did show that telehealthcare may result in a
reduction in the risk of admission to hospital for
asthma, particularly among people at high risk.
Explanation and comparison with other
studies
In contrast to our findings, a review by Duvvuri
concluded that information and communication
technologies can have a major role in helping a
much broader section of the population of people
with asthma.47 The inclusion criteria of that
review were broader than ours, in that the authors
searched for decision support and tools of patient
education in addition to the technologies in which
we were interested. Studies were summarized in
narrative form and no meta-analyses were
attempted. Duvvuri and colleagues also drew
attention to some favourable analyses of cost
effectiveness and patient satisfaction. In addition,
they identified the remaining hurdle of physician
licensing and re imbursement when care is deliv-
ered via tele healthcare. This is particularly an
issue in countries where physicians claim a fee
for service from a health insurance provider, such
as in Canada and the United States. We would be
more cautious in recommending rapid adoption
and implementation of telehealthcare strategies
without further evaluation.
Limitations
The first limitation to consider is our definition
of telehealthcare. Our definition rules out several
interventions that others may argue do constitute
telehealthcare because it stipulates that a health
care professional must be actively involved with
the ongoing delivery of the intervention. Our
definition excluded technologies for self care
and self education and websites.
Our definition also included basic technologies,
particularly the telephone. We justify the telephone
as a legitimate form of telehealthcare because it
very effectively enables personalized health care
over a distance, and it has been included in many
programs of telehealthcare. Telehealthcare does
not have to be new, novel or sophisticated, and the
telephone is a legitimate and well-researched
medium for providing  telehealthcare.
In general, the level of intervention may vary
in telehealthcare, with tasks delegated to less
senior, less expensive health care professionals
and to patients themselves for self-care when
their asthma is stable. This variation may lead to
more effectively tailored care. For example, tele-
healthcare can be supported by computer algo-
rithms when asthma is well controlled, or it can
involve more sophisticated telemonitoring when
a patient’s condition is less stable (i.e.,  “hospital
at home” monitoring). The benefits of telehealth-
care are mediated by education, an enhanced
therapeutic relationship, more intensive monitor-
ing of the patient and feedback. The precise mix-
ture of these elements has not been measured by
the different studies in this review; however,
these elements are important and they should be
studied further as per the research framework for
complex interventions of the United Kingdom’s
Medical Research  Council.48
Only four studies could be included to assess
the effect of telehealthcare on admission to hospi-
tal. This is either because the other studies were
too small or the follow-up period was too short to
include patients who were admitted to hospital, or
because the studies included only patients with
mild asthma and there were no admissions to hos-
pital. Because a large number of different scales
for symptoms were used, meta-analysis across
studies was not done for this outcome. Likert-type
patient-satisfaction scores were reported in a num-
ber of studies and generally re flected a high level
of satisfaction. However, the disadvantage of such
scales is that detailed information is not gathered
because of the limitations of a longitudinal scale.
Complementing this type of literature with future
qualitative research will help us to understand
what has been missed in terms of value from the
perspective of the patients and that of physicians
who deal with the less severe end of the spectrum
of asthma.
Conclusions and implications for further
research
Telehealthcare is no worse than normal care in its
ability to improve quality of life in carefully
selected and triaged patients receiving primary
and secondary care. It does not appear more able
to improve quality of life than routine models of
care, nor does it appear to reduce the number of
visits a patient makes to the emergency depart-
ment. Studies with larger intervention and control
groups are needed to confirm these results with
precision. We did, however, find that admissions
to hospital decreased. It may be useful to consider
focusing certain telehealthcare interventions on
groups with higher risk. Further research should
look at stratifying the risk of admission to hospital
and relating it to the effectiveness of telehealth-
care intervention.
Many of the patients in the control arms of the
studies received enhanced face-to-face care for
their asthma rather than usual care, so it was par-
ticularly challenging to show the benefits of tele-
healthcare in these comparisons. Future studies
should make comparisons with usual care to best
judge whether telehealthcare offers any improve-
ment, or equivalence studies should be done if
Research
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the population in the control group receives
enhanced care. Considerably more research is
also needed to investigate the cost effectiveness
of telehealthcare-centred models of care.
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